COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Fan, G.; Yang, Z.; Lin, Q.; Zhao, S.; Yang, L.; He, D. Decreased Case Fatality Rate of COVID-19 in the Second Wave: A study in 53 countries or regions. Transbound. Emerg. Dis. 2021, 68, 213–215. [Google Scholar] [CrossRef] [PubMed]
- Grasselli, G.; Tonetti, T.; Protti, A.; Langer, T.; Girardis, M.; Bellani, G.; Laffey, J.; Carrafiello, G.; Carsana, L.; Rizzuto, C.; et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: A multicentre prospective observational study. Lancet Respir. Med. 2020, 8, 1201–1208. [Google Scholar] [CrossRef]
- Calabrese, F.; Pezzuto, F.; Fortarezza, F.; Boscolo, A.; Lunardi, F.; Giraudo, C.; Cattelan, A.; Del Vecchio, C.; Lorenzoni, G.; Vedovelli, L.; et al. Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure. J. Pathol. 2021, 254, 173–184. [Google Scholar] [CrossRef] [PubMed]
- Zarrilli, G.; Angerilli, V.; Businello, G.; Sbaraglia, M.; Traverso, G.; Fortarezza, F.; Rizzo, S.; De Gaspari, M.; Basso, C.; Calabrese, F.; et al. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int. J. Mol. Sci. 2021, 22, 974. [Google Scholar] [CrossRef] [PubMed]
- The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med. 2021, 384, 693–704. [Google Scholar] [CrossRef] [PubMed]
- Saito, S.; Asai, Y.; Matsunaga, N.; Hayakawa, K.; Terada, M.; Ohtsu, H.; Tsuzuki, S.; Ohmagari, N. First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics. J. Infect. 2021, 82, 84–123. [Google Scholar] [CrossRef] [PubMed]
- Bongiovanni, M.; Arienti, R.; Bini, F.; Bodini, B.D.; Corbetta, E.; Gianturco, L. Differences between the waves in Northern Italy: How the characteristics and the outcome of COVID-19 infected patients admitted to the emergency room have changed. J. Infect. 2021, 83, e32–e33. [Google Scholar] [CrossRef] [PubMed]
- Koehler, P.; Bassetti, M.; Chakrabarti, A.; Chen, S.C.A.; Colombo, A.L.; Hoenigl, M.; Klimko, N.; Lass-Flörl, C.; Oladele, R.O.; Vinh, D.C.; et al. Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect. Dis. 2021, 21, e149–e162. [Google Scholar] [CrossRef]
- Fortarezza, F.; Boscolo, A.; Pezzuto, F.; Lunardi, F.; Acosta, M.J.; Giraudo, C.; Del Vecchio, C.; Sella, N.; Tiberio, I.; Godi, I.; et al. Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure. Mycoses 2021. epub ahead of print. [Google Scholar] [CrossRef]
- Buehler, P.K.; Zinkernagel, A.S.; Hofmaenner, D.A.; Garcia, P.D.W.; Acevedo, C.T.; Gómez-Mejia, A.; Shambat, S.M.; Andreoni, F.; Maibach, M.A.; Bartussek, J.; et al. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep. Med. 2021, 2, 100229. [Google Scholar] [CrossRef] [PubMed]
- Borczuk, A.C.; Salvatore, S.P.; Seshan, S.V.; Patel, S.S.; Bussel, J.B.; Mostyka, M.; Elsoukkary, S.; He, B.; DEL Vecchio, C.; Fortarezza, F.; et al. COVID-19 pulmonary pathology: A multi-institutional autopsy cohort from Italy and New York City. Mod. Pathol. 2020, 33, 2156–2168. [Google Scholar] [CrossRef] [PubMed]
- de Ana, S.G.; Torres-Rodríguez, J.M.; Ramírez, E.A.; García, S.M.; Belmonte-Soler, J. Seasonal distribution of Alternaria, Aspergillus, Cladosporium and Penicillium species isolated in homes of fungal allergic patients. J. Investig. Allergol. Clin. Immunol. 2006, 16, 357–363. [Google Scholar]
FIRST WAVE (March–August 2020) | SECOND WAVE (September 2020–February 2021) | |
---|---|---|
Number of autopsies | 153 | 160 |
Age range | <70: 33% 71–80: 33% >80: 33% | <70: 33% 71–80: 67% >80: 0% |
Gender | Males: 85 (56%) Females: 68 (44%) | Males: 91 (57%) Females: 69 (43%) |
Number of comorbidities | 1: 12% 2–3: 44% >3: 44% | 1: 12% 2–3: 76% >3: 12% |
Number of CAPA cases | 4 | 21 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fortarezza, F.; Pezzuto, F.; Hofman, P.; Kern, I.; Panizo, A.; von der Thüsen, J.; Timofeev, S.; Gorkiewicz, G.; Berezowska, S.; de Leval, L.; et al. COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic. Diagnostics 2022, 12, 95. https://doi.org/10.3390/diagnostics12010095
Fortarezza F, Pezzuto F, Hofman P, Kern I, Panizo A, von der Thüsen J, Timofeev S, Gorkiewicz G, Berezowska S, de Leval L, et al. COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic. Diagnostics. 2022; 12(1):95. https://doi.org/10.3390/diagnostics12010095
Chicago/Turabian StyleFortarezza, Francesco, Federica Pezzuto, Paul Hofman, Izidor Kern, Angel Panizo, Jan von der Thüsen, Sergei Timofeev, Gregor Gorkiewicz, Sabina Berezowska, Laurence de Leval, and et al. 2022. "COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic" Diagnostics 12, no. 1: 95. https://doi.org/10.3390/diagnostics12010095
APA StyleFortarezza, F., Pezzuto, F., Hofman, P., Kern, I., Panizo, A., von der Thüsen, J., Timofeev, S., Gorkiewicz, G., Berezowska, S., de Leval, L., Ortiz-Villalón, C., Lunardi, F., & Calabrese, F. (2022). COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic. Diagnostics, 12(1), 95. https://doi.org/10.3390/diagnostics12010095